Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01523223
Recruitment Status : Active, not recruiting
First Posted : February 1, 2012
Last Update Posted : November 18, 2016
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Robert Lowsky, Stanford University

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : September 2016
  Estimated Study Completion Date : December 2016